Authors
Latest:
Question and Answer about Neurofilament Light Chain and Other MS BiomarkersMark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, answer questions about biomarkers in MS care.
Latest:
Unmet Needs in the Treatment of Spinal Muscular AtrophyA panel of experts considers current unmet needs in SMA by emphasizing the need for further study of combination therapy, more comprehensive newborn screening, and more effective early diagnosis and treatment.
Latest:
Alexander Kolevzon, MD: The STARS Study in Angelman SyndromeThe director of Child and Adolescent Psychiatry at Mount Sinai Health System spoke about the results of the phase 2 study of OV101 (gaboxadol), and the next steps for the phase 3 trial.
Latest:
Unraveling the Complexity of Fatigue in Multiple Sclerosis: John DeLuca, PhDThe senior vice president for Research and Training at Kessler Foundation talked about the issue of fatigue in patients with multiple sclerosis and the significant, multifaceted challenges patients face. [WATCH TIME: 5 minutes]
Latest:
Hillary Thomas, PhD: Screening Patients With Epilepsy for DepressionThe pediatric psychologist at Children’s Medical Center discussed what her team does to assess patients in the clinic when something comes up as a result of a patient’s screening.
Latest:
Dan Barber, MBA: Advantages of Diazepam Buccal Soluble Film FormulationThe SVP and chief strategy and development officer at Aquestive Therapeutics discussed the hope to provide both patients and providers with a more favorable, and still efficacious, option for seizure clusters.
Latest:
How Big Data Can Drive Advancements in MS ResearchBig data is on the precipice of revolutionizing multiple sclerosis knowledge and treatment.
Latest:
Bernd Feige, PhD: Insomnia and the REM Sleep StateThe study presents direct evidence that subjective experiences of insomnia may be coupled to the REM sleep state.
Latest:
Everyone Is Working Hard: Why Shift Work Shouldn't Be CelebratedDanielle B. Cross, MD, MS, a neurology resident in training, shares her thoughts on why glorifying exhaustion is unhealthy.
Latest:
Raising Awareness for Spinal Muscular Atrophy and Improving Newborn Screening: Crystal Proud, MDThe director of neurology and neuromuscular medicine at the Children’s Hospital of the King’s Daughters in Norfolk, Virginia, discussed SMA Awareness Month and the enhancements to newborn screening for the disease. [WATCH TIME: 4 minutes]
Latest:
Addressing Specific Social Determinants of Health in Epilepsy: Joseph Sirven, MDThe professor of neurology at Mayo Clinic detailed ways to address social determinants of health and the gaps in care for patients with epilepsy.
Latest:
Margaret Moline, PhD: Next-Morning Residual Effects of Lemborexant in InsomniaThe International Project Team Lead spoke about the results of study endpoints that assessed the potential for next-morning residual effects of lemborexant, which is in development for insomnia.
Latest:
Navigating Insurance and Access Issues in MigraineCurrent hurdles faced by neurologists when prescribing therapy to treat migraine and advice to help other healthcare professionals as well as patients navigate insurance and access issues.
Latest:
Importance of Multidisciplinary Care in Management of Neurofibromatosis Type 1 Related Plexiform NeurofibromaKaleb Yohay, MD, an expert in NF1-PN, emphasizes the importance of multidisciplinary and comprehensive team care in managing the condition, detailing the essential team members required to facilitate a successful transition from adolescent to adult care.
Latest:
Uri Kramer, MD: Treating Epilepsy With CannabisThe professor of pediatrics at Tel Aviv University explained what has been fleshed out by the research and shared his opinion on cannabidiol’s use.
Latest:
Researching Dravet Syndrome Biomarkers to Advance Treatment: Christos Papadelis, PhDThe director of research in the Jane and John Justin Neurosciences Center at Cook Children's Health Care System talked about ongoing research on biomarkers to enhance treatment and improve cognitive outcomes. [WATCH TIME: 6 minutes]
Latest:
Sarah Wilson, PhD: Long-Term Social Outcomes of Epilepsy SurgeryThe clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne discussed the results of a study she and colleagues conducted in which they mapped the long-term social outcomes of patient post-epilepsy surgery.
Latest:
Conversations With Patients About Mild/Moderate Multiple SclerosisThe expert panel examines early multiple sclerosis (MS) and patients with mild MS even in later stages of the disease, emphasizing crucial information to convey to patients throughout their journey; faculty also explore cases where disease-modifying therapies (DMTs) may not be utilized.
Latest:
Multidisciplinary Care in Duchenne Muscular DystrophyEmma Ciafaloni, MD, addresses the important role of multidisciplinary care in the treatment of patients with Duchenne muscular dystrophy.
Latest:
Highly Effective Gene Therapies for SMA: Where Do We Go From Here?Neuromuscular medicine has entered an era of genetic therapy, opening the doors to questions about possible combination approaches and earlier initiation of treatment.
Latest:
Dravet Syndrome: Transition of Care Into AdulthoodJoseph Sullivan, MD, and Elaine C. Wirrell, discuss the transition of care into adulthood of patients with Dravet syndrome.
Latest:
Clinical Nurse Educators, Dosing Titrations to Manage Parkinson DiseasePanelists discuss how clinical nurse educators serve as vital partners in continuous subcutaneous apomorphine infusion management, providing patient education, troubleshooting technical issues, and collaborating with physicians on dosing titrations to optimize Parkinson disease symptom control.
Latest:
Future Directions in Research and TreatmentLooking to the future of multiple sclerosis care, the panel of thought leaders pose important questions that remain to be answered in the research and treatment of multiple sclerosis.
Latest:
Fred Rincon, MD, MSc: Increasing Use of Mobile Stroke UnitsThe chief of cerebrovascular disease at Jefferson University Hospitals detailed the importance and growth of mobile stroke units.
Latest:
Peter LeWitt, MD: Enhancing the Understanding of Parkinson for Therapeutic DevelopmentThe director of Parkinson’s Disease and Movement Disorders Program at Henry Ford Hospital discussed this pipeline of therapies and the enhancement of the clinical understanding of the disease.
Latest:
Intellectual and Electrophysiological Disturbances in the Definition of ‘Seizure’: Michael Sperling, MDAt the 2022 AES Conference, the Baldwin Keyes professor of neurology at Thomas Jefferson University talked about how clinicians and patients might define a seizure. [WATCH TIME: 3 minutes]
Latest:
Claudia Testa, MD, PhD: Pairing Huntington Disease TreatmentsThe professor of neurology at VCU spoke about the possibility of pairing gene therapies for Huntington disease down the line when they are available.
Latest:
Question and Answer about Neurofilament Light Chain and Other MS BiomarkersMark Freedman, MD, MSc, Tanuja Chitnis, MD, and Ahmed Obeidat, MD, PhD, answer questions about biomarkers in MS care.
